Interventions in the Acute Phase of Myocardial Infarction

Interventions in the Acute Phase of Myocardial Infarction edited by J. Morganroth, E. Neil Moore.

In the 1980's a primary focus for intense cardiovascular research is in the treatment of patients with acute myocardial infarction. Although the prevalence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Morganroth, J. (Editor), Moore, E. Neil (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer US : Imprint: Springer, 1984.
Edition:1st ed. 1984.
Series:Developments in Cardiovascular Medicine, 41
Springer eBook Collection.
Subjects:
Cardiology.
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Models to Study Experimental Infarction
  • 1 Experimental Models and Endpoints for Evaluating Interventions in the Acute Phase of Myocardial Infarction — An Anatomic Approach
  • 2 Models to Study Experimental Infarction — Pharmacologic
  • 3 Pharmacokinetics of Anti-Arrhythmic Agents in Acute Myocardial Infarction
  • Indices to Define Infarct Size
  • 4 Limitations of Electrophysiologic Techniques in Defining Myocardial Infarct Size
  • 5 Estimates of Injury after Infarction Evolving Spontaneously or in Response to Coronary Thrombolysis
  • 6 Measurement of Myocardial Infarct Size Using Nuclear Cardiology Methods
  • 7 Echocardiographic Approaches to the Evaluation of Acute Myocardial Infarction
  • 8 Two Dimensional Echocardiography in Acute Myocardial Infarction: Clinical Applications
  • 9 Panel on Indices to Define Infarct Size Moderator
  • Pharmaceutical Interventions to Reduce Infarct Size
  • 10 The Case for Prophylactic Lidocaine in Acute Myocardial Infarction
  • 11 Infarct Size Reduction by Antiarrhythmic Prophylaxis — A Contrary View
  • 12 Pharmaceutical Interventions to Reduce Infarct Size — Streptokinase
  • 13 Streptokinase in Acute Myocardial Infarction
  • 14 Vasodilators in Acute Myocardial Infarction
  • 15 Panel on Pharmaceutical Interventions to Reduce Infarct Size Moderator
  • 16 Early Intravenous Atenolol in Suspected Acute Myocardial Infarction: Final Report of a Randomized Clinical Trial
  • 17 Calcium Channel Blockers and Limitation of Myocardial Infarction Size
  • 18 Steroid Treatment of Acute Myocardial Infarction: Some Implications for Clinical Trials in General
  • 19 Evaluation of Inotropic Therapy
  • 20 Panel on Pharmaceutical Interventions to Reduce Infarct Size Moderator
  • Devices to Limit Infarct Size
  • 21 Transluminal Coronary Angioplasty
  • 22 Devices to Limit Infarct Size: Ventricular Assist Devices
  • 23 Internal Electrical Devices to Limit Infarct Size
  • 24 Devices to Limit Infarct Size — FDA Evaluation
  • 25 Panel on Devices to Limit Infarct Size
  • Summary of Symposium on New Drugs and Devices
  • Participant List.

Similar Items